Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 327

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1A
Chunk 327
---
 of RSUs at the beginning of each fiscal year. The (i) stock options are subject to vesting and (ii) RSUs are
subject to vesting and represent the right to be issued on a future date shares of our common stock upon vesting.

Please see above under the heading "Equity
Transactions in the Fiscal Year Ended March 31, 2025—RSU Grants to Non-Employee Directors" for disclosure regarding equity
awards under the Director Compensation Policy during the fiscal year ended March 31, 2025.

STOCK OPTION ACTIVITY

During the fiscal years ended March 31, 2025 and
March 31, 2024, we did not issue stock option grants.

Options outstanding that were vested as of March
31, 2025 and options that are expected to vest subsequent to March 31, 2025 are as follows:

    Schedule of options outstanding that have vested and are expected to
    vest 

    Number of Shares  
    Weighted Average Exercise Price  
    Weighted Average Remaining Contractual Term in Years 
  
    Vested 
     5,795  
    $132.82  
     6.02 
  
    Expected to vest 
     751  
    $112.80  
     6.87 
  
    Total 
     6,546  

The following is a summary of the stock options
outstanding at March 31, 2025 and 2024 and the changes during the years then ended:

    Schedule of stock option activity 

    Fiscal Year Ended March 31, 

    2025  
    2024 

    Options  
    Weighted  Average  Exercise Price  
    Options  
    Weighted Average  Exercise Price 
  
    Outstanding, beginning of year 
     10,816  
    $146.22  
     21,491  
    $180.93 
  
    Granted 
     –  
    $–  
     –  
    $– 
  
    Cancelled/Forfeited 
     (4,270) 
    $170.29  
     (10,675) 
    $215.12 
  
    Outstanding, end of year 
     6,546  
    $130.52  
     10,816  
    $146.22 
  
    Exercisable, end of